CASTOR1 regulates humoral immune responses and contributes to the pathogenesis of systemic lupus erythematosus

Study limitation reported by the research below: “The impact flag 'practice changing' reflects the novelty of CASTOR1 as a therapeutic target concept, not an established clinical intervention — no drug targeting CASTOR1 is currently approved.”